None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Aged 20 to 90 years -Chronic stroke patients at least 3 months after onset -Unilateral hemiparesis -Functional Ambulation Category (FAC) levels 2–4 -Patients who can follow the therapist’s instructions for gait training -Patients who agree to participate in the study
Exclusion criteria
Exclusion criteria: -Presence of gait or balance disorders caused by diseases other than stroke (e.g., gait abnormalities due to Parkinson’s disease, peripheral neuropathy, myopathy, arthropathy) -History of epileptic seizures or current treatment for epilepsy -Use of medications, procedures, or surgeries within the past month that may affect gait training -Unstable vital signs -Ongoing treatment for malignant diseases -Severe depression or psychiatric disorders that may interfere with treatment compliance -Severe aphasia that prevents effective communication -Cognitive impairment that prevents understanding of instructions (Clinical Dementia Rating, CDR = 1) -Receiving other treatments during the study period that may affect gait function (e.g., patients who received botulinum toxin injections or joint replacement surgery) -Confirmed pregnancy or currently breastfeeding -Participation in another clinical study -Inability to understand the purpose of the study or comply with study-related procedures -Any other condition that, in the investigator’s judgment, makes participation in the clinical trial inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 10 meter walking test | — |
Secondary
| Measure | Time frame |
|---|---|
| MMT(Manual Muscle Test);TUG(Timed Up and Go test);FAC(Functional Ambulation Category;BBS(Berg Balance Scale);K-MBI(K-Modified Barthel Index);EQ-5D-3L;Gait analysis | — |
Countries
Korea, Republic of
Contacts
Chonnam National University Hospital